Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
14 hedge funds and large institutions have $84.5K invested in Novo Integrated Sciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
12.97% less ownership
Funds ownership: 13.49% → 0.51% (-13%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
91% less capital invested
Capital invested by funds: $954K → $84.5K (-$870K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$17.4K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$11.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$9.55K |
| 5 |
AWM
Axxcess Wealth Management
Carlsbad,
California
|
+$7.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$508K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$301K |
| 3 |
Renaissance Technologies
New York
|
-$44K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35.2K |
| 5 |
HF
HRT Financial
New York
|
-$8K |
NVOS Hedge Fund Activity: Q1 2023 in Review
14 of the 6,285 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q1 2023, worth a combined $84.5K — down 91% from $954K a quarter earlier.
Fund positioning in NVOS was balanced in Q1 2023: 6 funds opened new positions, 6 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $17.4K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $508K sold.
- 14 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $84.5K of Novo Integrated Sciences, Inc. Common Stock stock for Q1 2023, down 91% quarter-over-quarter.
- 6 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q1 2023 and 6 closed out, a net change of 0 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q1 2023 was Virtu Financial, an estimated $17.4K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q1 2023 was Hudson Bay Capital Management, an estimated $508K sold.
Based on aggregated 13F filings for Q1 2023.